{"product_id":"cjc-1295-no-dac-ipamorelin-10mg","title":"CJC 1295 no dac + ipamorelin 10mg","description":"\u003cdiv class=\"markdown markdown-main-panel md-content enable-updated-hr-color force-compact-layout stronger tutor-markdown-rendering\" id=\"model-response-message-contentr_d0ef7b5530cabbb9\" dir=\"ltr\"\u003e\n\u003cdiv\u003e\n\u003cb\u003eSafe Vials\u003c\/b\u003e CJC-1295 No-DAC + Ipamorelin is a co-formulated, dual-action research blend pairing two distinct growth hormone secretagogues that act through independent receptor pathways. Supplied as a stable, co-lyophilized powder, this combination features Modified GRF (1–29) paired alongside Ipamorelin (a selective pentapeptide ghrelin receptor agonist).\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv\u003eBy simultaneously engaging both the Growth Hormone-Releasing Hormone (GHRH) receptor on pituitary somatotrophs and the Growth Hormone Secretagogue Receptor (GHS-R1a), \u003cb\u003eSafe Vials\u003c\/b\u003e CJC-1295 No-DAC + Ipamorelin enables researchers to study synergistic stimulation of growth hormone release in a single, standardized reagent. Furthermore, Ipamorelin's exceptional receptor selectivity ensures minimal cross-activation of cortisol or prolactin pathways, preserving clean experimental parameters. Every lot is independently third-party tested and HPLC-verified (\u003cstrong\u003e≥ 98%\u003c\/strong\u003e purity for both components) to ensure precise ratio consistency and reproducible laboratory results.\u003c\/div\u003e\n\u003cbr\u003e\u003chr\u003e\n\u003ch2\u003eCompound Information\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eProduct Name:\u003c\/b\u003e Safe Vials CJC-1295 No-DAC + Ipamorelin\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eClassification:\u003c\/b\u003e Dual-Pathway GH Secretagogue Blend (GHRH Analog + Selective Ghrelin Receptor Agonist)\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eCAS Registry Numbers:\u003c\/b\u003e 863288-34-0 (CJC-1295 No-DAC) \/ 170851-70-4 (Ipamorelin)\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\u003cb\u003eMolecular Formulas:\u003c\/b\u003e\u003c\/div\u003e\n\u003cbr\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003ci\u003eCJC-1295 No-DAC:\u003c\/i\u003e \u003cstrong\u003eC₁₅₂H₂₅₂N₄₄O₄₂\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003ci\u003eIpamorelin:\u003c\/i\u003e \u003cstrong\u003eC₃₈H₄₉N₉O₅\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\u003cb\u003eMolecular Weights:\u003c\/b\u003e\u003c\/div\u003e\n\u003cbr\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003ci\u003eCJC-1295 No-DAC:\u003c\/i\u003e 3367.90 g\/mol\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003ci\u003eIpamorelin:\u003c\/i\u003e 711.86 g\/mol\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\u003cb\u003eAmino Acid Sequences:\u003c\/b\u003e\u003c\/div\u003e\n\u003cbr\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003ci\u003eCJC-1295 No-DAC (29 AA):\u003c\/i\u003e Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-\u003cstrong\u003eNH₂\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003ci\u003eIpamorelin (5 AA):\u003c\/i\u003e Aib-His-D-2-Nal-D-Phe-Lys-\u003cstrong\u003eNH₂\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch2\u003eResearch Highlights\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eDual Receptor Synergy:\u003c\/b\u003e Combines a GHRH receptor agonist with a selective GHS-R1a agonist, allowing investigation into additive and synergistic signaling pathways converging on identical cellular outputs.\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eSomatostatin Inhibition:\u003c\/b\u003e Ipamorelin actively dampens somatostatin activity (the native inhibitory brake on GH secretion), allowing CJC-1295 to drive maximal receptor stimulation unhindered.\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eHigh Receptor Selectivity:\u003c\/b\u003e Unlike older-generation secretagogues, Ipamorelin demonstrates negligible affinity for ACTH, cortisol, or prolactin receptors, providing cleaner data sets without off-target hormonal spikes.\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003ePulsatile Release Kinetics:\u003c\/b\u003e Rapid clearance profiles of both un-conjugated peptides mimic natural physiology by producing discrete, natural-like secretion pulses rather than unnatural, continuous elevations.\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eCo-Lyophilized Ratio Control:\u003c\/b\u003e Pre-mixed and co-lyophilized in precise proportion to guarantee homogeneous concentration across all laboratory draws.\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch2\u003eProduct Specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003ePhysical Form:\u003c\/b\u003e Co-lyophilized solid powder\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eVisual Appearance:\u003c\/b\u003e Fine white to off-white cake\/powder\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003ePurity Level:\u003c\/b\u003e \u003cstrong\u003e≥ 98%\u003c\/strong\u003e (HPLC-verified for both individual peptide components)\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eSolubility:\u003c\/b\u003e Readily soluble in sterile water or bacteriostatic water\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\u003cb\u003eStorage Requirements:\u003c\/b\u003e\u003c\/div\u003e\n\u003cbr\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003ci\u003eUnopened (Lyophilized):\u003c\/i\u003e Keep tightly sealed and dry at \u003cb\u003e-20°C\u003c\/b\u003e for long-term storage (or \u003cb\u003e2–8°C\u003c\/b\u003e for short-term handling). Protect from light and moisture.\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003ci\u003eReconstituted Solution:\u003c\/i\u003e Store under refrigeration at \u003cb\u003e2°C – 8°C\u003c\/b\u003e. Aliquot working stocks to minimize repeated freeze-thaw cycles.\u003c\/div\u003e\n\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003e\n\u003cb\u003eUsage Disclaimer:\u003c\/b\u003e Strictly for \u003ci\u003eIn Vitro\u003c\/i\u003e Laboratory Research and Development Use Only. Not for human consumption, therapeutic, or diagnostic applications.\u003c\/div\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"Safe Vials","offers":[{"title":"Default Title","offer_id":57863795114366,"sku":null,"price":109.0,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1008\/9109\/9518\/files\/CJC_1295_no_dac_ipamorelin_10mg.png?v=1787137471","url":"https:\/\/safevials.com\/products\/cjc-1295-no-dac-ipamorelin-10mg","provider":"Safe Vials","version":"1.0","type":"link"}